Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Arizona for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Arizona only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Arizona (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Mark Barakat (NPI 1225214646)

Field	Value
Entity Type	Individual
Organization	Mark Barakat
Address	20201 N Scottsdale Healthcare Dr
City	Scottsdale
State	AZ
ZIP	85255
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 16, 2008

Payer Source	Total Paid
Medicare	$3M
Medicaid	$0

Key Findings

The provider’s code mix is strongly retina-focused: the top revenue drivers are intravitreal biologic injections (J2777, J0178, J2778) supported by high-volume retinal imaging (92134) and a mix of retina procedures (67028, 67036, 67042). This pattern indicates an ophthalmology practice organized around frequent in-office injections and diagnostics with a modest surgical retina component rather than a general ophthalmology or optometry practice.

Revenue is highly concentrated in a few drug codes: the precomputed top 3 Medicare codes by revenue account for 79.3% of this provider's total Medicare revenue, led by J2777 at $1.2M (40.0%), J0178 at $717.3K (24.3%), and J2778 at $441.2K (15.0%). That concentration means the practice’s Medicare revenue profile is driven primarily by anti-VEGF and related biologic therapy administration.

Payer mix is effectively single‑payer Medicare: lifetime Total Medicare revenue is $3M while there is no Medicaid billing on file, so the provider operates without a Medicaid footprint on available claims data. This lack of Medicaid activity suggests the provider’s patient base and revenue flows are overwhelmingly Medicare-driven.

Competitive standing on the top drugs is solid but not monopolistic: J2777 ranks #162 of 2039 (92th percentile; typical, unremarkable volume), J0178 ranks #1253 of 3204 (61th percentile; typical, unremarkable volume), and J2778 ranks #157 of 1208 (87th percentile; typical, unremarkable volume). These ranks indicate the provider treats more patients with these agents than many peers nationally but is not an extreme outlier or clear national leader in injection volume for all three agents.

The provider shows extreme and notable outlier activity in certain diagnostics and E/M codes: 92134 ranks #331 of 26868 (99th percentile; extreme outlier, far above typical national volume), 99203 ranks #2796 of 161519 (98th percentile; extreme outlier, far above typical national volume), and 67028 ranks #330 of 4255 (92th percentile; notably above typical national volume). In plain terms, retinal imaging and certain evaluation/management visits are far higher than typical peers, signaling either high throughput for diagnostic follow-up or a focused referral stream for retinal disease.

Surgical retina activity exists but is a smaller share of revenue: 67028 generates $194K (6.6%) and ranks #330 of 4255 (92th percentile; notably above typical national volume), while 67036 ($18.8K, 0.6%) and 67042 ($23.2K, 0.8%) sit at more typical national volumes. This suggests the practice performs some vitreoretinal procedures in addition to injections and imaging, with the majority of revenue coming from office-based therapeutic and diagnostic services.

Ancillary supplies and miscoded or unclassified drug entries are present but small contributors: J7999 accounts for $57.6K (2.0%) and ranks #68 of 1333 (95th percentile; typical, unremarkable volume), J3490 accounts for $47.7K (1.6%) and ranks #2361 of 2838 (15th percentile; typical, unremarkable volume), and J7312 accounts for $26.5K (0.9%). These line items reflect modest additional revenue sources related to compounded drugs and other injectable supplies but do not materially diversify the provider’s revenue base.

The provider has long tenure on file — NPI enumerated 2008-01-16 (~18 years ago) — and the combination of sustained high imaging volume (92134) and concentrated biologic injection revenue suggests an established retina-oriented practice with an entrenched Medicare referral pattern in Scottsdale, AZ. Given the $3M Medicare lifetime revenue and the concentration in a few high-value codes, strategic shifts in drug utilization or reimbursement for intravitreal therapies could meaningfully affect this provider’s revenue profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	40,740	$30	$1.2M
J0178	Injection, aflibercept, 1 mg	1,040	$690	$717.3K
J2778	Injection, ranibizumab, 0.1 mg	2,450	$180	$441.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,130	$90	$194K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,190	$30	$89.4K
J7999	Compounded drug, not otherwise classified	810	$70	$57.6K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	610	$90	$52.2K
J3490	Unclassified drugs	30	$1,770	$47.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	580	$60	$36.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	170	$160	$26.5K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Arizona Distribution

Mark Barakat — 4 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Arizona

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	22	50	780	$690	$734.8K
J2777	6	50	9,000	$30	$525.8K
J2778	5	30	550	$180	$198K
67028	13	60	1,240	$90	$119K
J7312	20	20	270	$160	$48.9K
J7999	14	50	490	$70	$46.8K
67042	22	40	30	$1,160	$46.5K
67036	11	30	30	$1,030	$37.9K
67108	15	20	20	$1,230	$33.2K
99214	1,064	10,410	120	$80	$20.6K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Mark Barakat, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Gila River Health Care Corporation	AZ	Ambulance	$0	$40M
Southwestern Eye Center Ltd	AZ	Ophthalmology Physician	$0	$15.9M
Barnet Dulaney Perkins Eye Center, PC	AZ	Ophthalmology Physician	$0	$10.9M
Gila River Health Care Corporation	AZ	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$6.7M
Sujit Itty	AZ	Ophthalmology Physician	$6.2M	$11.3K
Retinal Consultants Of Arizona Ltd	AZ	Ophthalmology Physician	$0	$6.2M
David Goldenberg	AZ	Retina Specialist (Ophthalmology) Physician	$4.7M	$15.8K
Neal Palejwala	AZ	Ophthalmology Physician	$4.4M	$2.9K
Sachin Mehta	AZ	Retina Specialist (Ophthalmology) Physician	$4.4M	$11.8K
Ronald Hobbs	AZ	Ophthalmology Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Mark Barakat, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Az Med Transportation	AZ	Non-emergency Medical Transport (VAN)	$0	$23.1M
Reliable In Home Care, LLC	AZ	In Home Supportive Care Agency	$0	$16M
Honorhealth	AZ	General Acute Care Hospital	$0	$7.4M
Richard Lee Averitte Jr PLLC	AZ	Dermatology Physician	$0	$7.1M
Franklyn Gergits	AZ	Otolaryngology Physician	$1.3M	$0
Digestive Health Specialists Endoscopy Center Arizona, LLC	AZ	Ambulatory Surgical Clinic/Center	$1M	$104.7K
Sarah Estrada	AZ	Dermatopathology Physician	$1.1M	$20.2K
Christine Lin	AZ	MOHS-Micrographic Surgery Physician	$1.1M	$0
Urology Asc- Phoenix, LLC	AZ	Ambulatory Surgical Clinic/Center	$883.6K	$0
Kevin Fuciarelli	AZ	Specialist	$603.3K	$0

Mark Barakat — Billing Profile & Reimbursement Data

Sign up for Mark Barakat — Billing Profile & Reimbursement Data policy alerts

Mark Barakat — Billing Profile & Reimbursement Data

Sign up for Mark Barakat — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References